FzioMed reaches 400k-unit milestone of Oxiplex gel manufacture: 5 takeaways

FzioMed has shipped 400,000 units of Oxiplex gel.

Advertisement

Here are five takeaways:

 

1. Oxiplex is an absorbable gel that is applied to spinal nerve roots during lumbar laminectomy, laminotomy and discectomy procedures for the treatment of herniated discs.

 

2. Oxiplex’s efficacy has been shown in numerous clinical trials.

 

3. Oxiplex is approved outside the United States in 70 countries.

 

4. It is distributed under the brand names Oxiplex, Oxiplex/SP and MediShield.

 

5. FzioMed is a privately held medical device company that develops, manufactures and markets absorbable surgical biomaterials.

 

More articles on devices:
15 things to know about Zimmer Biomet
DePuy Synthes invests $60M in expanded manufacturing plant in Ireland: 4 things to know
3D Systems named to top 50 ‘smartest companies’ list: 5 observations

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.